Podcasts about researchers

State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015–23 Health Affairs While medications for opioid use disorder (MOUD) is effective treatment, most patients with OUD don't receive it and prior authorization (PA) has been a barrier to access. Researchers looked at state policies trying to address this barrier, specifically for private health insurance, between 2015 and 2022. Some states adopted “full prohibitions” against PAs while others adopted “partial prohibitions” that allowed PA under some circumstances. Overall, the number of states with at least some prohibition increased from 2 in 2015 to 22 in 2023. In addition, 7 states adopted “full prohibitions” initially, while 15 adopted “partial prohibitions”, with 4 of those 15 transitioning to “full prohibitions” later. Additional research will be needed to assess the impact of these prohibitions, but this study elucidates the current landscape of policy.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Welcome to Ozempic Weightloss Unlocked. Today, we are diving into the latest news and updates on Ozempic, a drug reshaping how we think about weight loss, health, and lifestyle.In the past year, millions of people have turned to Ozempic, part of a group of medications called GLP-1 receptor agonists. Originally created to manage blood sugar for people with type 2 diabetes, Ozempic's appetite-suppressing effects have made it a sought-after tool for weight management. According to the Pennington Biomedical Research Center, these medications were developed from a compound first found in the saliva of the Gila monster lizard. It is amazing to think that a hormone from a desert reptile is now changing lives in clinics around the world.One of the most important updates is accessibility. The White House recently announced a deal with drug makers Eli Lilly and Novo Nordisk to cut prices for Ozempic and related drugs. The average monthly cost, once more than one thousand dollars, could now be as low as fifty to three hundred fifty dollars a month, depending on your insurance. Kim Fisher of the UC Davis Innovation Institute for Food and Health says around one in eight adults in the United States—about forty-one million people—have already used GLP-1 drugs. Lower prices open the door for many more people to take advantage of these treatments.For listeners looking for alternatives to injections, there is more good news. Novo Nordisk recently released results from a study on an oral pill version of Ozempic's sister drug, Wegovy. The New England Journal of Medicine reports that this once-daily pill resulted in an average weight loss of sixteen point six percent—almost identical to the weekly injection. While the pill is not yet approved by the Food and Drug Administration, it may become a game-changer for those seeking a needle-free option. Novo Nordisk says they hope to set a new benchmark for oral weight loss medications pending approval.If you are wondering whether these drugs only affect the scale, the answer is no. According to research from UC Davis and the University of California San Diego, GLP-1 drugs not only promote weight loss, but may also offer broader health benefits. Some of the latest studies show that these medications can lower cardiovascular risk, benefit blood pressure, and even reduce the risk of major events like heart attacks and stroke.Researchers at UC San Diego found that GLP-1 use among people with colon cancer was tied to much lower death rates—fifteen point five percent for those on the drugs, versus thirty-seven point one percent for those who were not. While the exact reasons are still being studied, experts believe these medications reduce inflammation, improve insulin sensitivity, and might even directly inhibit the growth of cancer cells.The way GLP-1 drugs work is by mimicking a natural hormone produced in your gut after eating. They help your body feel full longer, lower blood sugar, and curb cravings—especially for sweets and fatty foods. Patients often report that the constant mental chatter about food is quieter, making it easier to stick to healthy habits.With all the benefits, it is important to mention common side effects. Many users experience nausea, vomiting, or diarrhea, particularly when starting or increasing doses. Doctors recommend pairing treatment with a nutrient-dense diet, regular exercise, and enough protein to help preserve muscle mass.Experts are also discussing the need for ongoing research into the long-term effects and best practices for managing side effects. As these drugs become more widely used, scientists are working to make sure weight loss translates into lasting improvements for health and well-being.That is all for today's episode of Ozempic Weightloss Unlocked. Thank you for tuning in. To stay up to date on the next wave of news and breakthroughs, remember to subscribe. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Bangladesh's former prime minister Sheikh Hasina has been found guilty of crimes against humanity and sentenced to death. A tribunal in Dhaka found she had ordered security forces to kill protesters during student-led anti-government demonstrations in 2024. The UN estimates up to 1,400 people died during the uprising, most by gunfire. Sheikh Hasina was tried in her absence and has been living in exile in India since being forced from power. She has dismissed the court's verdict as politically motivated. Also: a plea from the UN aid chief to stop the supply of weapons to the rival armies in Sudan. A BBC investigation has uncovered evidence raising doubts about the trial of US marines over the killings of Iraqi civilians in 2005. Researchers look to artificial intelligence to treat a type of brain cancer, by detecting early signs that tumours are returning. And we drop in on a knitting session in Denmark to find out why young people are driving a boom in traditional crafts.The Global News Podcast brings you the breaking news you need to hear, as it happens. Listen for the latest headlines and current affairs from around the world. Politics, economics, climate, business, technology, health – we cover it all with expert analysis and insight. Get the news that matters, delivered twice a day on weekdays and daily at weekends, plus special bonus episodes reacting to urgent breaking stories. Follow or subscribe now and never miss a moment. Get in touch: globalpodcast@bbc.co.uk

The Pentagon is spending millions on AI hacking. The New York Times investigates illicit crypto funds. Researchers uncover widespread remote code execution flaws in AI inference engines. Police in India arrest CCTV hackers. Payroll Pirates use Google Ads to steal credentials and redirect salaries. A  large-scale brand impersonation campaign delivers Gh0st RAT to Chinese-speaking users.A bitcoin mining company CEO gets scammed. Monday biz brief. On our Industry Voices segment with our Knowledge Partner SpecterOps, Chief Technology Officer Jared Atkinson is discussing Attack Path Management: Identities in Transit. Bitcoin big wigs learn to bite through plastic. Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest On our Industry Voices segment with our Knowledge Partner SpecterOps, Chief Technology Officer Jared Atkinson is discussing Attack Path Management: Identities in Transit. Hear more from Jared here. Cyber Things podcast Something strange has landed in all the cool podcast apps… Cyber Things is a new three-part series from Armis that decodes real-world cyber threats through the lens of a certain Hawkins-based sci-fi phenomenon. Just in time for the show's final season, Rebecca Cradick leads us through a world where fiction meets cybersecurity. Because sometimes the scariest villains aren't in the Upside Down — they're online. You can check out Cyber Things on your favorite podcast app and on our website. On the site, you will find the trailer and Episode 1: The Unseen World available today! Selected Reading The Pentagon Is Spending Millions On AI Hacking From Startup Twenty (Forbes) The Crypto Industry's $28 Billion in ‘Dirty Money' (The New York Times) The Coin Laundry, a global cryptocurrency investigation (International Consortium of Investigative Journalism) "ShadowMQ" exploit pattern reported in major AI frameworks, enables remote code execution (Beyond Machines) Gujarat: Hackers steal maternity ward CCTV videos in India cybercrime racket (BBC News) Payroll Pirates: One Network, Hundreds of Targets (Check Point) Digital Doppelgangers: Anatomy of Evolving Impersonation Campaigns Distributing Gh0st RAT (Unit 42, Palo Alto Networks) Inside a Wild Bitcoin Heist: Five-Star Hotels, Cash-Stuffed Envelopes, and Vanishing Funds (WIRED) UK prosecutors seize £4.11M in crypto from Twitter mega-hack culprit (The Register) Tenzai emerges from stealth with $75 million in seed funding led by Greylock Partners.  (N2K Pro) How to Not Get Kidnapped for Your Bitcoin (The New York Times) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show. Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textAre you stuck in the cycle of doing more but not actually growing? In this powerful conversation, leadership researcher and bestselling author Ryan Gottfredson breaks down the crucial difference between being and doing and why upgrading who you are matters far more than upgrading your to-do list.Whether you're a leader, creator, entrepreneur, or someone navigating burnout, this episode will help you understand why traditional self-improvement often fails… and what it really takes to transform your life from the inside out.With Ryan, we explore why high achievers often hit invisible ceilings, why burnout keeps returning, and how your inner operating system — your mindsets, nervous system, identity, and sense-making — determine the quality of your relationships, leadership, and long-term success.In today's world, we're taught to hustle harder, learn more skills, collect certifications, and keep pushing. But Ryan reveals a life-changing truth:Real transformation doesn't start with doing more; it begins with becoming more.Together, we explore why high achievers often hit invisible ceilings, why burnout keeps returning, and how your inner operating system, your mindsets, nervous system, identity, and sense-making determine the quality of your relationships, leadership, and long-term success.What You'll Learn in This Episode:✅ The game-changing difference between horizontal vs. vertical development✅ Why the most skilled people still struggle to lead effectively✅ How your childhood wiring shapes your adult decision-making✅ What “heat experiences” are and how they can fuel rapid growth✅ Practical tools for strengthening self-regulation and emotional resilience✅ How to shift out of self-protection and into value creation✅ Why you can't outwork or outthink a dysregulated nervous system✅ How identity, confidence, and self-worth impact your leadership✅ Simple daily practices to develop your “being” sideWhy You Should Watch:If you're ready to lead with clarity, reduce burnout, and unlock deeper personal transformation, this episode is for you.Connect with Ryan Gottfredson

Researchers in Puerto Rico are building a system designed to warn people down to the block in San Juan. Learn more at https://www.yaleclimateconnections.org/ 

You managed to find the episode. Now search for where Copilot App Skills are re-moving in Excel. Find out how Copilot can reschedule meetings for you if you get double-booked. Find a way for Researcher and Analyst agents to connect to other agents and use them - sub-contracting!   0:00 Welcome 1:57 App Skills in Excel will be retired - MC1184407 4:31 Agent mode in Excel generally available soon (formerly part of the Frontier program) - MC1184408 7:19 Microsoft 365 Copilot: Configure connected agents for Researcher and other agents - MC1184654 14:28 Copilot can now automatically reschedule 1:1 meetings and personal events based on your preferences - MC1184999 22:25 Decoupling admin controls for agents on/off from Researcher and Analyst - MC1185442 26:07 Microsoft 365 Copilot: Steer your presentation length, tone, style, and images when creating with Copilot - MC1185911 30:35 Microsoft Purview compliance portal: Purview Information Protection | Classifier Simulation Mode (Health Monitoring) - MC1185445

Fresh off the biggest OneDrive moment of the year, Stephen and Arvind return with a full recap of the Copilot + OneDrive event—breaking down the announcements, the behind-the-scenes surprises, and the features that are already reshaping how we work. From personalized intelligence with the FAB button to the future of search, photos, and Researcher, the team walks through the four major themes of the show and shares what it was like to step on camera as part of the launch. They even react to the unexpected blooper reel that made its way into the final cut! This episode also features a special guest: Belle Podeanu, product manager behind the brand-new Transfer Ownership experience. Belle walks through how the team redesigned this critical workflow end-to-end—from modernized emails to shared-file filtering to smarter move-and-keep-sharing options—all built to reduce data loss and simplify transitions when employees leave.

Today's headlines include: Opposition Leader Sussan Ley has downplayed questions surrounding her leadership and says she’s confident she’ll lead the Coalition into the next federal election. A four-day NSW Police operation has led to 752 people being arrested and charged with domestic violence-related offences. Gen Z-led protests in Mexico City turned violent on the weekend, leaving 120 people injured. And today’s good news: Researchers say they’re on the cusp of a malaria breakthrough, after a new drug was found to be more than 97% effective at treating the disease. Hosts: Emma Gillespie and Lucy TassellProducer: Rosa Bowden Want to support The Daily Aus? That's so kind! The best way to do that is to click ‘follow’ on Spotify or Apple and to leave us a five-star review. We would be so grateful. The Daily Aus is a media company focused on delivering accessible and digestible news to young people. We are completely independent. Want more from TDA?Subscribe to The Daily Aus newsletterSubscribe to The Daily Aus’ YouTube Channel Have feedback for us?We’re always looking for new ways to improve what we do. If you’ve got feedback, we’re all ears. Tell us here.See omnystudio.com/listener for privacy information.

Adam Smith narrates his blog written for Dementia Researcher. In this blog Adam offers clear guidance for people seeking their first research assistant role. It explains how building a visible online presence, following authors whose work you admire, reaching out for short conversations, and engaging with communities can help you stand out. It also covers job alerts, broadening the types of roles you consider, attending webinars and conferences, volunteering for small tasks, and preparing strong applications by matching the person specification. Find the original text, and narration here on our website. https://communities.dementiaresearcher.nihr.ac.uk/c/undergradudate/if-you-just-left-university-you-probably-got-some-336de1da-5d76-48f5-8027-0408ad5bb8a6 -- Adam Smith was born in the north, a long time ago. He wanted to write books, but ended up working in the NHS, and at the Department of Health.  He is now Programme Director in the Office of the NIHR National Director for Dementia Research (which probably sounds more important than it is) at University College London. He has led a number of initiatives to improve dementia research (including this website, Join Dementia Research & ENRICH), as well as pursuing his own research interests. In his spare time, he grows vegetables, builds Lego & spends most of his time drinking too much coffee and squeezing technology into his house. -- Enjoy listening? We're always looking for new bloggers, drop us a line. http://www.dementiaresearcher.nihr.ac.uk This podcast is brought to you in association with Alzheimer's Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia, who we thank for their ongoing support. -- Follow us on Social Media: https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/ https://twitter.com/demrescommunity https://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.social Join our community: https://onelink.to/dementiaresearcher

The Green Belt and Rethinking Liberty 30 Years Later. Matthew Longo reflects that thirty years after the Iron Curtain fell, the border site is now an unremarkable "green belt." Researcher Longo considers the meaning of freedom, contrasting Isaiah Berlin's negative liberty—freedom from state interference—with Hannah Arendt's concept of plurality and solidarity. He notes the disappointment felt by some East Germans who missed the community they knew in the East. Guest: Matthew Longo. Retry

Researchers attempted to message extraterrestrials on this day in 1974. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Beneath Antarctica's icy surface lies a hidden mountain range as tall as the Alps — the mysterious Gamburtsev Mountains. Formed over 500 million years ago, this ancient range has been buried under kilometers of ice, preserved like a time capsule. Discover how scientists uncovered this lost world using radar and seismic data, and what these ancient peaks reveal about Earth's dramatic past. Learn more about your ad choices. Visit megaphone.fm/adchoices

Sam Bankman-Fried BioSnap a weekly updated Biography.Sam Bankman-Fried is back in the headlines, though not for any new exploits—unless you count lobbying from behind bars. According to Morning Brew, SBF, once celebrated as a Forbes 30 Under 30 “whiz kid” in 2021, is now memorialized in their Hall of Shame, serving a 25-year sentence for seven counts of fraud connected to his orchestration of FTX's multibillion-dollar collapse. The outlet notes he is actively petitioning President Trump for a pardon, a move analysts consider highly unlikely. Markets.com assigns just a 4 percent chance of that pardon ever arriving, making the effort seem more a desperate gambit for relevance than a credible bid for freedom.In terms of business activity, FTX itself is now a relic. As Galaxy Digital's newsletter observes, this week marks the third anniversary of the FTX implosion, a fever dream in crypto lore where Bankman-Fried resigned under a cloud of scandal and bankruptcy attorneys took over. By now, the estate under John J. Ray III has clawed back enough assets to pay 100 percent of official customer claims, with distributions starting to reach affected users—though at November 2022 prices, leaving some feeling shortchanged as crypto valuations surged after the collapse.Bankman-Fried has tried to shape the public's understanding of his downfall. CoinMarketCap reports he's been using messages from prison to argue FTX was solvent and that bankruptcy lawyers are at fault for delays in asset recovery, claims roundly rejected by the official estate and largely dismissed by industry observers as self-serving. Meanwhile, TheStreet notes his verified account continues to make waves on social media, most recently by mocking blockchain sleuth ZachXBT with pointed, if implausible, allegations connecting him to Binance CEO Changpeng Zhao, signaling SBF remains undeterred in stirring drama behind the wire.In the wider media, Sam Bankman-Fried's story is now a recurring cautionary tale. Recent episodes from the Aspen Ideas Festival featured acclaimed author Michael Lewis, who shadowed Sam for months for his book "Going Infinite," dissecting how SBF's blend of ambition and naivety created a cult of fast money and misplaced trust. Researchers and commentators at Ivey Business School and elsewhere use Bankman-Fried's arc to explain the media's role in sculpting—then shredding—tech founders' reputations, with SBF serving as the patron saint of the boom-to-bust narrative.On social media, references to Sam remain persistent, as crypto influencers and legal analysts debate his case's parallels with a growing rogues' gallery of 2025 crypto fraudsters. Discussions continue around the supposed regulatory schemes he floated with the SEC, with Uniswap's founder alleging SBF's pitch to classify bitcoin and ether as securities was narrowly thwarted by FTX's collapse.In sum, Sam Bankman-Fried is not fading quietly into prison obscurity. He remains a fixture of headlines and podcasts, his name invoked by advocates and detractors alike as the symbol of crypto's wild excesses and the lasting need for tighter oversight.Get the best deals https://amzn.to/3ODvOtaThis content was created in partnership and with the help of Artificial Intelligence AI

Collectively, the results of this study position A. conyzoides as a promising, safe, and well-tolerated adjunct or alternative to current pharmacological approaches. Further investigations of longer duration and larger sample sizes, incorporating imaging measures, are warranted to confirm efficacy.A plant commonly known as "billygoat weed" (Ageratum conyzoides) has a long tradition of use in ethnomedicine for a wide range of conditions, including rheumatism, inflammatory pain, fever, and headaches.Building on this history, a recent 12-week, double-blind, randomized, placebo-controlled study investigated its effect on osteoarthritis (OA) symptoms in ageing adults. The study included 70 adults aged 45 and older with clinically diagnosed osteoarthritis. Participants were given either 250 mg of a special pyrrolizidine alkaloid-free A. conyzoides extract or a placebo to take daily for 12 weeks.Researchers found that the group taking A. conyzoides had statistically significant reductions in their total WOMAC scores (a measure of pain, stiffness, and function) compared to the placebo group at both week 9 and week 12. Pain scores, measured by the Visual Analogue Scale (VAS), were also significantly lower for the supplement group at weeks 9 and 12.Furthermore, the A. conyzoides group showed significant improvements in quality-of-life domains related to pain and role limitations due to physical health. The supplement also significantly reduced plasma levels of two inflammatory markers, IL-6 and IL-8, compared to placebo. The study concluded that A. conyzoides supplementation is a safe and effective option for reducing osteoarthritis symptoms.3. Disclaimers• This information is for educational purposes only and should not be interpreted as medical advice.• The study discussed was conducted on human adults aged 45 and older with clinically diagnosed mild-to-moderate osteoarthritis. The findings may not apply to individuals with severe OA or other conditions.• Always consult with a qualified healthcare professional before making any changes to your diet, supplement regimen, or treatment plan, especially if you have a medical condition or are taking medications.________________________________________Rao A, Gorman A, Subah S, Muntha S, Bogoda N, Briskey D. Effect of Ageratum Conyzoides on Osteoarthritis in an Ageing Adult Population: A Double-Blind Randomized Placebo-Controlled Parallel Study. Nutraceuticals. 2025;5(4):35. doi:10.3390/nutraceuticals5040035#AgeratumConyzoides #Osteoarthritis #JointPainRelief #ClinicalTrial #AntiInflammatoryAgeratum conyzoides, osteoarthritis, OA, joint pain, joint stiffness, joint function, WOMAC, Visual Analogue Scale, SF-36, quality of life, IL-6, IL-8, inflammatory markers, nutraceuticals, anti-inflammatory, analgesic, billygoat weed, randomized controlled trial, placebo-controlled study, ageing adult population, pyrrolizidine alkaloid-free, herbal medicine, alternative medicine, osteoarthritis treatment, Gencor Pacific Ltd

This is a Grave Talks CLASSIC EPISODE! The Mothman first spread its wings over Point Pleasant, West Virginia, in the 1960s—an era of fear, mystery, and tragedy. After a wave of sightings and supernatural panic, the terror culminated in the catastrophic collapse of the Silver Bridge, cementing Mothman as one of America's most chilling legends. For decades, the creature vanished—until whispers of its return began to surface near Lake Michigan in 2017. Researcher and investigator Tobias Wayland joins the conversation to uncover the truth behind this winged enigma. Are the modern-day encounters with Mothman mere folklore reborn, or is the creature an ancient harbinger of doom following humanity through the decades? From eyewitness accounts to eerie coincidences and mass sightings over the Midwest, this is a story that refuses to fade. Because when the Mothman appears, history suggests tragedy is never far behind. #TheGraveTalks #Mothman #LakeMichiganMothman #Cryptids #CryptidLegends #PointPleasant #SilverBridgeCollapse #ParanormalPodcast #UrbanLegends #Cryptozoology #WingedCreature #HarbingerOfDoom #RealMystery Love real ghost stories? Don't just listen—join us on YouTube and be part of the largest community of real paranormal encounters anywhere. Subscribe now and never miss a chilling new story:

LSD shows promise for anxiety treatment. A Phase 2b clinical trial found that 100 micrograms of MM120 (pharmaceutical LSD) reduced anxiety significantly with lasting effects Study results were encouraging. Researchers noted that 65% of participants experienced clinical response at optimal dosing, with 47.5% achieving remission that sustained through 12 weeks of follow-up Safety profile was manageable. Most side effects occurred during dosing sessions and resolved quickly, with visual changes and nausea being most common under medical supervision Note that LSD remains illegal. It is currently classified as Schedule I controlled substance, accessible only through approved clinical trials, with results of Phase 3 trials expected by 2026 In the meantime, natural anxiety alternatives exist. Breathing techniques like nasal breathing, horizontal breathing patterns, and controlled breathing practices can help manage anxiety symptoms without medication

Today, we’re bringing you the best from the KUOW Newsroom. US health secretary Robert F Kennedy, Jr., has announced what he thinks are at least one cause and one cure for autism. Local researchers are pushing back on those claims. And this summer, the Trump administration eliminated funding that helps children from migrant families attend college. We’ll learn about what that means for Washington students. We can only make Seattle Now because listeners support us. Tap here to make a gift and keep Seattle Now in your feed. Got questions about local news or story ideas to share? We want to hear from you! Email us at seattlenow@kuow.org, leave us a voicemail at (206) 616-6746 or leave us feedback online.See omnystudio.com/listener for privacy information.

For decades, most medical and biological research has been conducted primarily on male volunteers and male animals in laboratory studies. One of the main reasons was convenience - male hormone levels are more stable, whereas female hormones shift across the menstrual cycle, introducing variability that researchers historically preferred to avoid. But that convenience has come at a cost. When treatments are developed and tested mainly in males, the results don't always translate well to female physiology. This means that women have often been prescribed medications or therapies that were never fully tested on their biology. In some cases, women have experienced more side effects, reduced effectiveness, or entirely different outcomes than men. As we learn more, it's becoming clear that male and female bodies age differently too. And new anti-ageing treatments may need to take these differences into account. A new study published in the journal Ageing shows exactly why. The researchers discovered a combination of two drugs that extended lifespan in frail, elderly male mice by an impressive 73 percent from the start of treatment while also improving their mobility, endurance and memory. However, the same therapy did not provide the same benefits to female mice. They tested oxytocin, which is known to support tissue repair, along with another drug known as OT+A5i, which blocks a key pathway involved in regulating cell growth, differentiation, and death. The study involved 25-month-old mice which is roughly equivalent to a 75-year-old human. In male mice: Lifespan increased by 73 percent from the start of treatment. Median lifespan increased by 14 percent. Risk of death at any time decreased three-fold. Endurance, grip strength, and agility improved. Short-term memory improved. Blood biomarkers shifted toward younger, healthier levels. But in female mice: No significant extension of lifespan. No consistent improvements in strength or memory. Blood biomarkers did not shift in the same way. Researchers suggest several possibilities for the difference: Female inflammatory signalling pathways differ from males Hormonal environments change ageing differently in men and women The interaction between oxytocin and TGF-beta networks may not play the same role in female tissues This highlights the point that ageing is not identical in men and women, and treatments to slow ageing may need to be tailored accordingly. See omnystudio.com/listener for privacy information.

This is a Grave Talks CLASSIC EPISODE! The Mothman first spread its wings over Point Pleasant, West Virginia, in the 1960s—an era of fear, mystery, and tragedy. After a wave of sightings and supernatural panic, the terror culminated in the catastrophic collapse of the Silver Bridge, cementing Mothman as one of America's most chilling legends. For decades, the creature vanished—until whispers of its return began to surface near Lake Michigan in 2017. Researcher and investigator Tobias Wayland joins the conversation to uncover the truth behind this winged enigma. Are the modern-day encounters with Mothman mere folklore reborn, or is the creature an ancient harbinger of doom following humanity through the decades? From eyewitness accounts to eerie coincidences and mass sightings over the Midwest, this is a story that refuses to fade. Because when the Mothman appears, history suggests tragedy is never far behind. #TheGraveTalks #Mothman #LakeMichiganMothman #Cryptids #CryptidLegends #PointPleasant #SilverBridgeCollapse #ParanormalPodcast #UrbanLegends #Cryptozoology #WingedCreature #HarbingerOfDoom #RealMystery Love real ghost stories? Don't just listen—join us on YouTube and be part of the largest community of real paranormal encounters anywhere. Subscribe now and never miss a chilling new story:

In this week's episode, I speak with Professor Michael Pluess, renowned temperament researcher, to explore what it really means to have a "sensitive" child. We break down the science behind sensitivity as a key part of temperament, why some kids are more reactive to both positive and negative experiences, and how parenting can shape their outcomes. We discuss the genetic and environmental roots of sensitivity, common misunderstandings around the trait, and what parents can do to support emotional regulation.I WROTE MY FIRST BOOK! Order your copy of The Five Principles of Parenting: Your Essential Guide to Raising Good Humans Here: https://bit.ly/3rMLMsLSubscribe to my free newsletter for parenting tips delivered straight to your inbox: draliza.substack.com Follow me on Instagram for more:@raisinggoodhumanspodcast Sponsors:Gruns: Visit gruns.co and use code HUMANS at checkout for up to 52% off your first orderClean Safe Products: Go to cleansafeproducts.com/HUMANS now to get $15 off the Green Mitt KitKendra Scott: Visit kendrascott.com/gifts and use code RGH20 at checkout for 20% off ONE full-priced jewelry itemFlavCity: Visit Shop FlavCity.com and use code GOODHUMAN15 at checkout for 15% off Wayfair: Head to Wayfair.com now to shop Wayfair's Black Friday deals for up to 70% offQuince: Go to Quince.com/humans for free shipping on your order and 365-day returnsSuvie: Check out Suvie's Black Friday Sale for extra savings while it lasts. Go to Suvie.com/Humans to get $150 off plus 16 free meals when you order during their salePlease note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week on A Week In Her Wallet, we head to Atlanta to follow Kristen, a 40-something clinical researcher who earns about $150K a year and travels nearly full-time for work. She walks us through a week of thoughtful spending, including a $1,300 mortgage payment, $500 toward her HELOC, a $150 yard sale win (promptly spent on music festival tickets), and the small joys that keep her grounded when she's on the road so much.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

(November 14, 2025) AT&T wants to axe landlines in California… here’s who may be hurt. Researchers say they have verified and sequenced Hitler’s DNA… a new documentary reveals the findings. President Trump asks Israel’s president to pardon Netanyahu from corruption charges. The luxury electric vehicle is in trouble.See omnystudio.com/listener for privacy information.

Nate and Todd welcome a new friend of the show for this outstanding guest chat! Enjoy Creepies…Katie Paige!!!

Researchers have created a device with 6100 qubits, the largest collection of quantum bits ever assembled, using an array of ultracold caesium atoms controlled by lasers. As New Scientist explains, the breakthrough marks a significant step toward building the world's most advanced quantum computer. Previously, the record was held by a machine from Atom Computing with 1180 qubits. The new device uses neutral atoms cooled to near absolute zero, and is designed to maintain stable quantum states for longer periods. You can listen to all of the Quantum Minute episodes at https://QuantumMinute.com. The Quantum Minute is brought to you by Applied Quantum, a leading consultancy and solutions provider specializing in quantum computing, quantum cryptography, quantum communication, and quantum AI. Learn more at https://AppliedQuantum.com.

In this episode, Steve is joined by Sir Bryan M. Bowden, Leading Cryptozoologist, UFO Researcher & Investigator, Paranormal Remote Viewer. Find Sir Bryan here: https://linktr.ee/bryanmbowdenBecome a supporter of this podcast: https://www.spreaker.com/podcast/missing-persons-mysteries--5624803/support.

The Outer Realm welcomes back Laura DiDio Date: November 13th, 2025 EP: 641 TOPIC: Laura DiDio returns for PT 2- The 52 year anniversary of the DeFeo Murders. She was the News Reporter who was brought in by the Lutzes and given full access to the house, she will discuss never before shared or disclosed information. If time allows she will share some of her paranormal experiences at the Conjuring House and more! - -Broke “The Amityville Horror” story obtaining the exclusive interview for Channel 5's 10 O'clock news and produced the pieces on the séance with numerous psychics including Ed and Lorraine Warren and later, separately with the late Hans Holzer. Contact for the show - theouterrealmcontact@gmail.com Michelle Desrochers and The Outer Realm :https://linktr.ee/michelledesrochers_ Please support us by Liking, Subscribing, Sharing and Commenting. Thank you all !!! About Laura DiDio: • Experienced in researching news and feature television, radio and print articles on wide range of psychics, mediums, paranormal investigators and hauntings. Worked extensively with and interviewed a wide range of paranormal investigators including Dorothy Allison, Uri Geller, Hans Holzer, Ethel Johnson Meyers, Vicki Monroe, Shawn Robbins and Ed and Lorraine Warren. • Award winning Reporter, Producer and Researcher. • Broke “The Amityville Horror” story obtaining the exclusive interview for Channel 5's 10 O'clock news and produced the pieces on the séance with numerous psychics including Ed and Lorraine Warren and later, separately with the late Hans Holzer. Also worked with the Warrens investigating the paranormal events experienced by the Perron family at their Rhode Island farmhouse, which served as the basis for the 2013 movie, “The Conjuring.” • Reporter and Co-Producer of “My Amityville Horror” documentary released in 2013. • Reporter and Producer of numerous series on psychic phenomenon, paranormal experiences and mediums for CNN and Channel 5's 10 O'clock News. • Well versed in interviewing, background research, locating and booking interview subjects, setting up location shoots, copyediting, transcription/editing of interviews and proofreading. • Objective, impartial reporting and analysis of events with strong commitment to absolute accuracy while getting the story. • Familiar with all aspects of production. Strong technical command of the English language; familiarity with news, documentary and feature writing styles; serious commitment to excellence in the televised and published word. • Frequent radio and TV guest subject matter expert on paranormal events. When not investigating paranormal events, Laura DiDio is an investigative reporter who has extensive experience uncovering corruption. She has also spent over 20 years as a high technology reporter and industry analyst covering firms like Apple, IBM, HPE, Lenovo, Microsoft, Oracle and others. If you enjoy the content on the channel, please support us by “Liking, Subscribing, Sharing and Commenting: Thank you All A formal disclaimer: The opinions and information presented or expressed by guests on The Outer Realm Radio are not necessarily those of the TOR Hosts, Sponsors, or the United Public Radio Network and its producers. We will however always be respectful and courteous to all involved. Thank you, we appreciate you all!

Researchers at the University of Exeter examined different ways to prevent the birds from approaching a box of chips on the ground. Birdsong and a recording of a male voice shouting 'No, stay away, that's my food' were played to 61 herring gulls across 9 seaside towns in Cornwall. Almost half of the seagulls flew away within a minute of being exposed to the shouting voice, while 70 per cent of the gulls stayed near the food when the birdsong was playing.What's your best seagull scare?

Researchers created vitamin K analogues that cross the blood-brain barrier more effectively, which eventually turn into the bioactive form, menaquinone-4 (MK-4) Higher levels of MK-4 in brain tissue correlate with 17% to 20% lower dementia risk and reduced Alzheimer's-related brain damage Vitamin A's active form, retinoic acid, enhances synaptic plasticity and memory formation, with deficiencies linked to cognitive impairment and neuropsychiatric disorders Both vitamin K and retinoic acid signaling naturally decrease with aging, contributing to reduced neurogenesis and weakened memory circuits in older adults Consume K2-rich fermented foods, pair with healthy fats for absorption, combine with vitamin D3 and magnesium, and include vitamin A sources like leafy greens

Operation Endgame expands global takedowns. The U.S. is creating a Scam Center Strike Force. Microsoft rolls out its delayed “Prevent screen capture” feature for Teams. Proton Pass patches a clickjacking flaw. Researchers uncover previously undisclosed zero-day flaws in both Citrix and Cisco Identity Services Engine. Android-based digital picture frames contain multiple critical vulnerabilities. Lumma Stealer rebounds after last month's doxxing campaign. Our guest is Garrett Hoffman, Senior Manager of Cloud Security Engineering from Adobe, talking about achieving cloud security at scale. X marks the spot… where your passkey stops working.  Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest On our Industry Voices segment, we are joined by Garrett Hoffman, Senior Manager of Cloud Security Engineering from Adobe, talking about achieving cloud security at scale. You can hear the full conversation with Garrett here. Selected Reading End of the game for cybercrime infrastructure: 1025 servers taken down - Operation Endgame's latest phase targeted the infostealer Rhadamanthys, Remote Access Trojan VenomRAT, and the botnet Elysium (Europol) US announces ‘strike force' to counter Southeast Asian cyber scams, sanctions Myanmar armed group (The Record) Microsoft rolls out screen capture prevention for Teams users (Bleeping Computer) Proton Pass patches DOM-based clickjacking zero-day vulnerability (Cyberinsider) Amazon discovers APT exploiting Cisco and Citrix zero-days (AWS Security Blog) CISA warns feds to fully patch actively exploited Cisco flaws (Bleeping Computer) Popular Android-based photo frames download malware on boot (Bleeping Computer) Increase in Lumma Stealer Activity Coincides with Use of Adaptive Browser Fingerprinting Tactics (Trend Micro) Elon Musk's X botched its security key switchover, locking users out (TechCrunch) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show. Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

Make sure you have the 1-2 combo of Magic Small Fish Feed and Easy Community Floating Pellets. https://www.aquariumcoop.com/products/magic-small-fish-feed  https://www.aquariumcoop.com/collections/all/products/easy-community-floating-pellets  Add Dr. James' field guide to your collection: https://a.co/d/0GmvbDs  Learn more about Dr. James Albert: https://biology.louisiana.edu/james-albert  Want to really nerd out? Check out this talk Dr. James gave at University of Michigan: https://youtu.be/1Qsk76-KDDk?si=8hPNcKKBHm7j2tCi  

In this episode of the Bigfoot Society Podcast, Jeremiah Byron talks with Rob from Idaho, a veteran Bigfoot researcher with over two decades of experience in the Pacific Northwest.Rob shares terrifying firsthand encounters from two of the most active Sasquatch hotspots in the United States — Loon Lake, Idaho and Bumping Lake, Washington.Hear about eerie yellow eye-shine, a strange siren-like howl, and the mysterious low-frequency hum that shook the ground during a BFRO expedition.You'll also learn about Rob's later investigations in Northern Idaho and the Sawtooth Mountains, his possible brush with a glowing orb, and what it's really like to search for Bigfoot in some of America's most remote wilderness.

YouTube TV-Disney battle may be nearing an end as dispute hits two-week mark, 'Grand Theft Auto 6' becomes the most-viewed trailer ever as games release date has been pushed to May 26 of 2026, Researchers using AI to help predict lightning-ignited wildfires, more science and technolgy news in this week's 'Tech It Out'

From Jeffrey Epstein and faking the moon landing, to chemtrails and who really killed JFK, Social Psychologist Dr. Daniel Jolley has spent his life studying conspiracy theories. We talk why people are drawn to conspiracy theories, what all major conspiracy theories have in common and the wildest conspiracy theories he's ever heard. Then, in the pointless part of the show, we countdown the Top 5 Life Lessons We Learned the Hard Way. Dr. Daniel Jolley: 01:08 Pointless: 26:23 Top 5 Life Lessons: 50:11 Contact the Show Dr. Daniel Jolley Website Dr. Daniel Jolley BlueSky How to Talk to Someone about Conspiracy Theories Learn more about your ad choices. Visit megaphone.fm/adchoices

These palm-sized robots use ultrasound signals to navigate harsh conditions in search and rescue missions. Also, the autocomplete will help users create more effective prompts for AI apps, resulting in fewer back-and-forths. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Researchers in Antarctica detected radio pulses “coming from below” the ice. What it it?

Everyday exposure to pesticides, even from conventionally grown fruits and vegetables, disrupts sperm function and reduces fertility in otherwise healthy men Researchers found that higher levels of pesticide residues in urine were linked to slower, less motile sperm, showing that even non-occupational exposure harms reproductive health Organophosphate pesticides damage sperm by disrupting calcium balance, impairing mitochondrial energy production, and oxidizing cell membranes, which reduces both movement and viability Global data confirm these effects, revealing consistent patterns of reduced sperm motility, concentration, and normal shape across men from multiple countries, even when hormone levels remain normal Reducing exposure through organic foods, filtered water, regular exercise, and sauna use helps your body eliminate stored toxins, restore mitochondrial energy, and rebuild sperm health within a few months

More than one in five babies are now born by C-section, and the numbers are expected to reach nearly one-third of all births by 2030, despite many cases lacking clear medical necessity Researchers from Stanford University found that C-section mothers were far more likely to experience severe postpartum pain and disrupted sleep, with over two-thirds reporting discomfort that interfered with rest and recovery Nationwide data showed that women who delivered by C-section were 16% more likely to develop new sleep disorders within a year after birth, including insomnia, sleep deprivation, and sleep apnea C-sections carry higher risks of infection, hemorrhage, blood clots, and complications in future pregnancies, while babies born this way face increased chances of respiratory distress, allergies, and autism Many cesarean deliveries can be avoided with the right preparation. Choosing a provider who supports natural birth, staying physically active, managing stress, and maintaining a healthy weight all lowers your risk

The storm that ravaged villages along Alaska's west coast may have washed away thousands of artifacts that promised to provide valuable insights into early Yup'ik settlements. The storm destroyed nearly 60 feet of shoreline near the village of Quinhagak. Along with it was a site that was the source of early masks, tools and other items that make up the world's largest collection of Yup'ik artifacts housed at the local museum. Researchers, who were already racing to recover the items threatened by thawing permafrost, say as many as 10,000 artifacts could be lost. In another blow, thieves made off with more than a thousand artifacts from the Oakland Museum of California's off-site storage facility. Oakland police and the FBI are working to find the culprits and recover the items. The early assessment by authorities suggest the heist may have been more of a crime of opportunity than a targeted operation. GUESTS Cody Groat (Kanyen'kehaka'), assistant professor at the Department of History and the Indigenous Studies Program at the University of Western Ontario  Shannon O'Loughlin (Choctaw), chief executive and attorney at the Association on American Indian Affairs Lynn Marie Church (Yup'ik), CEO of Nalaquq, LLC  Rick Knecht, emeritus senior lecturer in archaeology at the University of Aberdeen

In this episode of Cybersecurity Today, host David Shipley covers the latest threats in the cybersecurity landscape. Highlights include the emergence of the quantum root redirect (QRR) phishing kit, a sophisticated automated phishing platform targeting Microsoft 365 credentials across 90 countries. The hospitality industry is also being hit with a new 'click fix' phishing campaign, compromising booking systems and targeting hotel guests. Researchers discover new vulnerabilities in ChatGPT, exposing private data via indirect prompt injection attacks. Additionally, the University of Pennsylvania confirms a massive data breach, highlighting the risks of not implementing comprehensive MFA protocols. Stay informed with the latest cybersecurity news and insights to protect your organization. Cybersecurity Today would like to thank Meter for their support in bringing you this podcast. Meter delivers a complete networking stack, wired, wireless and cellular in one integrated solution that's built for performance and scale. You can find them at Meter.com/cst 00:00 Introduction and Sponsor Message 00:46 Quantum Root Redirect: A New Phishing Threat 03:47 Click Fix Phishing Attacks on Hotels 07:58 ChatGPT Vulnerabilities and AI Security Risks 11:37 University of Pennsylvania Data Breach 15:12 Conclusion and Call to Action

In this episode, I connect with Michela Grasso, a researcher and writer with the Urban Cycling Institute in Amsterdam, for a discussion about some of her recent projects, including the publication of A Manifesto for Cycling Futures and Planning the Cycling City: A Field Guide.Helpful Links (note that some may include affiliate links to help me support the channel):

The world record for fastest pit stop—a mere 1.8 seconds—was set by the McLaren F1 Team at the Qatar Grand Prix in 2023. It's an incredible feat of speed and choreography; a pit stop that fast can't happen without a team of people operating at peak human performance. But as Dan Keyworth explains, AI plays a crucial role, too. As the Director of Business Technology at McLaren Racing, Dan is responsible for helping the whole team perform at their best—and that starts with having the right tools. Whether it's the firehose of sensor data coming off a race car, video analysis of the pit crew in action, or marketing analytics for the next Grand Prix, AI helps the McLaren F1 Team make the right decisions—and make them fast.On this episode, Dan talks about the importance of getting simple answers from complex data, how they use Dropbox Dash, and why we shouldn't think of AI as labor replacement so much as laborious replacement.You can learn more about the McLaren F1 Team at mclaren.com/racing/formula-1. And if you haven't already seen it, be sure to watch their world record pit stop at youtube.com/watch?v=tRBOiq-Q6_s. Seriously, it's blink-and-you'll-miss-it fast.~ ~ ~Working Smarter is brought to you by Dropbox Dash—the AI universal search and knowledge management tool from Dropbox. Learn more at workingsmarter.ai/dashYou can listen to more episodes of Working Smarter on Apple Podcasts, Spotify, YouTube Music, Amazon Music, or wherever you get your podcasts. To read more stories and past interviews, visit workingsmarter.aiThis show would not be possible without the talented team at Cosmic Standard: producer Dominic Girard, sound engineer Aja Simpson, technical director Jacob Winik, and executive producer Eliza Smith. Special thanks to our illustrators Justin Tran and Fanny Luor, marketing consultant Meggan Ellingboe, and editorial support from Catie Keck. Our theme song was composed by Doug Stuart. Working Smarter is hosted by Matthew Braga. Thanks for listening!

We now call to the stand Günter Bäbler, a Titanic researcher and author so dedicated to understanding Titanic, he once kept a Junior Officer's sleep schedule of 4-hours-on and 4-hours-off for a whole week. His book “Guide to the Crew of Titanic” is a staple in the Witness Titanic library. This week, we ask him about all of this and more!BUY GÜNTER'S BOOK HEREVisit our Instagram for Episode VisualsorWATCH this episode on YouTube----------------------------------------------Welcome to WITNESS TITANIC — the podcast “inquiry” where we call witnesses of Titanic's great story, from modern experts to even the survivors of the sinking. Through their testimony, we navigate the uncertain waters of the Titanic legend, uncover what actually happened in April of 1912, and ultimately witness Titanic ourselves.This podcast is made possible by the generous support of the Witness Titanic Patrons, and is produced and hosted by Titanic researcher James Penca.LISTEN:Apple PodcastsSpotifyWATCH ON YOUTUBE:Season One | @WitnessTitanicSeason Two | ⁨@TitanicHG⁩MORE TITANIC CONTENT:Instagram | @WitnessTitanicPodTikTok | @WitnessTitanicPodJOIN THE INQUIRY:PatreonMusic recorded by Ege M. Erdogan | @egecomposerFor all inquiry-related inquiries, please email witnesstitanic@gmail.com Hosted on Acast. See acast.com/privacy for more information.

Researchers from Virginia Tech have discovered that ultra-processed meats and beverages are the worst for brain health. Individuals who consumed one or more extra servings of either of these foods showed a significantly increased risk of developing cognitive impairments, including those associated with forms of dementia such as Alzheimer's Disease. A recent article from Children's Health Defense shared new research ranking which junk foods are most harmful to the brain — and it's not just about kids' waistlines or sugar highs. It's about how what we eat can shape how we think, learn, and even feel. Let's dig into what this new research is saying, and more importantly, what it means for our families. How Junk Food Impacts the Brain These studies found that foods loaded with refined sugar, unhealthy fats, and artificial ingredients don't just harm the body — they change how the brain functions. Think of it like this: the brain runs on clear signals, kind of like a radio station. When it's getting clean fuel — whole foods, real nutrients — that signal is clear. But when it's constantly fed ultra-processed foods, it's like turning up the static. The brain starts to lose focus, memory gets fuzzy, and mood and motivation can shift. Ultra-Processed Foods (UPFs) are now known to include obesity, type 2 diabetes, cardiovascular diseases, anxiety, depression, and an increase in all-cause mortality. In fact, according to a study published in Diabetes Care, a journal of the American Diabetes Association, up to 220,000 young Americans under age 20 are likely to have Type 2 diabetes by 2060 — a 673% increase from 2017 levels. One of the studies found that people who ate a lot of processed meats, fried snacks, and sugary drinks had measurable changes in the areas of the brain that control memory and emotion. Another study showed that even short-term diets high in sugar and fat can rewire how the brain's “reward center” works — making people crave those same foods even more. A study of nearly 124,000 people found that drinking just one daily serving of artificially sweetened drinks increased the risk of a liver disease known as nonalcoholic fatty liver disease or metabolic dysfunction. That means the more we eat these foods, the more our brains want them, creating a loop that's hard to break. Why Kids Are Especially Affected Recent research has shed light on a startling concern—more than 300 chemicals have been detected in babies' cord blood and placenta at birth. This discovery highlights the fact that exposure to harmful chemicals begins much earlier than we previously thought. From conception through pregnancy, toxins can pass from the mother to the fetus, raising concerns about their potential long-term effects on child development and health. Children's brains are still developing, which makes them much more sensitive to these kinds of foods. When a growing brain is constantly exposed to sugary, processed foods, it can interfere with how nerve connections form. Some of the research cited by Children's Health Defense found that kids and teens who eat a lot of junk food have more trouble with memory and learning, and can experience more mood swings or attention issues. Part of that is because junk foods crowd out the nutrients that developing brains need — like omega-3s, zinc, and iron. And part of it is chemical: those processed ingredients can actually change the way the brain's reward systems respond, which makes healthy foods less appealing over time... Click Here or Click the link below for more details! https://naturallyrecoveringautism.com/233

Late autumn 1941. The Sunday service had just concluded. As their father lingered at the little north-country church, my dad and his siblings walked the short distance home. When their father came up the snowy hill to the farmhouse, he was crying. He’d just learned Pearl Harbor had been bombed. His sons—my dad included—would be going to war. Dad always recalled the moment in vivid detail. Researchers call such events “flashbulb memories”—moments seared into our minds. Think of 9/11, or the day you lost someone close. Think too of your most joyous experience. Imagine the flashbulb memories of Jesus’ disciples. They witnessed miracle after miracle. Suddenly, catastrophe struck. The Son of God was arrested and crucified. But then, resurrection! Mary Magdalene hurried to tell the disciples, “I have seen the Lord!” (John 20:18). Still, the disciples hid in fear. They didn’t believe the news (Luke 24:11), not until “Jesus came and stood among them” (John 20:19). Then, “The disciples were overjoyed” (v. 20). John recorded some of those moments, saying, “These are written that you may believe that Jesus is the Messiah, the Son of God, and that by believing you may have life in his name” (v. 31). “Flashbulb memories” with eternal significance.

Notes and Links to Jeff Pearlman's Work     Jeff Pearlman is the New York Times bestselling author of ten books. His subjects include the '80s Los Angeles Lakers (Show­time), the 1986 New York Mets (The Bad Guys Won), the '90s Dallas Cowboys (Boys Will Be Boys), and NFL legends Walter Pay­ton (Sweetness) and Brett Favre (Gunslinger). HBO adapted Showtime into the dramatic series Winning Time, produced and directed by Adam McKay. A former Sports Illus­trated senior writer and ESPN.com colum­nist, Pearlman is the host of the Two Writers Slinging Yang podcast and blogs regularly at jeffpearlman.com. Buy Only God Can Judge Me: The Many Lives of Tupac Shakur   Jeff's Website   NPR Coverage of Only God Can Judge Me: The Many Lives of Tupac Shakur At about 3:15, Jeff talks about writing against hagiography and how he doesn't “bring bias” into his writing, whether about Tupac or sports At about 5:25, Pete compliments the structure of the book, as it examines each of the places that shaped Tupac's life At about 5:55, Rapid-fire questions! *Best Tupac collab? Best movie role? At about 8:45, A beautiful shout-out to friend Curtis Dorsey and Jeff's dad, Stan At about 10:20, Jeff shouts out some favorite lines from Tupac's songs At about 10:50, Pete and Jeff discuss Tupac's “layering songs” and wondrous laugh  At about 12:55, Jeff responds to Pete's question about Jeff's “in”/entry point for writing about someone who has been written about so much  At about 15:45, Jeff expands on writing his biography of Tupac as a type of "layering" and the importance of specificity   At about 17:00, Jeff talks about how interviewing 652 people for his Tupac book is actually something that “[he] is supposed to do” At about 19:55, Jeff reflects a bit on book promotion and book release  At about 21:25, Jeff shouts out Dusty Baker as “maybe the coolest human being who's ever walked the planet” At about 22:20, Pete asks Jeff about Set Shakur's quote that Tupac died “alone”; Jeff reflects on the “isolation” of fame  At about 24:00, Jeff talks about Suge Knight and his indifference and his intriguing story At about 25:45, Jeff talks about Tupac's connection or lack thereof to the Mob Piru gang  At about 26:45, Pete gives an incomplete and rambling answer to the best Tupac song At about 28:10, Davonn Hodge and his mother reuniting due to great work by Jeff Pearlman and Michelle Soulli is discussed, as Jeff gives the background on the reunification  At about 30:20, Jeff gives background on Afeni Shakur's hometown, Lumberton, NC, and he gives a shoutout to Howard Bryant's book on Ricky Henderson At about 31:30, Jeff recounts a story about going to Lumberton to use the microfiche, but wound up seeing Tupac's grave At about 32:10, Jeff gives background on Afeni Shakur's amazing life and highlights her accomplishments and travails  At about 33:30, Jeff and Pete discuss “Dear Mama” as aspirational and the sadness of Afeni's substance abuse and how Tupac dealt with this horrible disappointment and “trauma” At about 35:15, Jeff talks in awe of Afeni's defending herself in the “Panther 21” trial At about 36:20, Jeff discusses Tupac's name origins At about 37:45, Jeff responds to Pete's question about Tupac's dad Billy Garland and male role models At about 39:40, The two discuss horrible athletic performances in movies and Tupac's unfortunate basketball shooting motion At about 41:00, Jeff gives some background on Tupac's birth name At about 41:40, Jeff talks about the impression that New York made on Tupac, musically and personally At about 43:00, The two discuss Tupac's time in Baltimore and at the Baltimore School for the Arts, and Tupac as an actor and singer; Jeff calls Baltimore his “favorite Tupac era” At about 45:10, The two talk about Tupac's Baltimore time and struggles and how “shapeshifter” didn't quite fit him At about 47:10, Jeff traces the Shakurs' move to Marin City and connections to Geronimo Pratt and his family At about 48:15, Jeff shares a profound statement from Set Shakur about moving vs. “relocating” At about 48:50, Jeff talks about Marin City and recreating the Marin City of when Tupac lived there  At about 50:50, Jeff expands on similarities between Tupac's time in the creative worlds of performing arts high schools in Baltimore and Marin City/ and his mother's downward spiral At about 51:55, The two discuss the significance of Marin City's Festival on the Green 1992 and further reporting on the tragedy as a “turning point” At about 55:50, Jeff responds to Pete's observation about Tupac's first albums not being highly-received and focuses on the changes that led to his second album being disappointing for Tupac At about 57:20, Jeff traces an almost parallel life for Tupac as a revolutionary leader in Atlanta At about 58:45, Jeff talks about the awkward time with Tupac working to become a community leader  At about 1:00:20, Jeff responds to Pete's question about the reactions from people who were wowed by Tupac's raps in person At about 1:03:00, Jeff shares what he learned in his interviews about Tupac the actor At about 1:06:00, Jeff shares his thoughts on the alleged second sexual assault by Tupac At about 1:08:15, Pete and Jeff discuss the “fan[ning] of the hip hop media/media and Tupac's  At about 1:09:35, Pete compliments the skillful ways in which the last hours and days (the “banal”) were rendered in the way  At about 1:11:10, Pete asks Jeff about how much Death Row changed Tupac/brought out tendencies in him At about 1:12:55, Jeff shares information from the book on two or three parallel universes where Tupac almost avoided being in Las Vegas   At about 1:13:55, Jeff reflects on Tupac as a 54 year old      You can now subscribe to the podcast on Apple Podcasts, and leave me a five-star review. You can also ask for the podcast by name using Alexa, and find the pod on Stitcher, Spotify, and on Amazon Music. Follow Pete on IG, where he is @chillsatwillpodcast, or on Twitter, where he is @chillsatwillpo1. You can watch other episodes on YouTube-watch and subscribe to The Chills at Will Podcast Channel. Please subscribe to both the YouTube Channel and the podcast while you're checking out this episode.       Pete is very excited to have one or two podcast episodes per month featured on the website of Chicago Review of Books. The audio will be posted, along with a written interview culled from the audio. His conversation with Hannah Pittard, a recent guest, is up at Chicago Review.     Sign up now for The Chills at Will Podcast Patreon: it can be found at patreon.com/chillsatwillpodcastpeterriehl      Check out the page that describes the benefits of a Patreon membership, including cool swag and bonus episodes. Thanks in advance for supporting Pete's one-man show, DIY podcast and extensive reading, research, editing, and promoting to keep this independent podcast pumping out high-quality content!    This month's Patreon bonus episode features an exploration of flawed characters, protagonists who are too real in their actions, and horror and noir as being where so much good and realistic writing takes place.    Pete has added a $1 a month tier for “Well-Wishers” and Cheerleaders of the Show.     This is a passion project, a DIY operation, and Pete would love for your help in promoting what he's convinced is a unique and spirited look at an often-ignored art form.    The intro song for The Chills at Will Podcast is “Wind Down” (Instrumental Version), and the other song played on this episode was “Hoops” (Instrumental)” by Matt Weidauer, and both songs are used through ArchesAudio.com.     Please tune in for Episode 309 with Amber Sparks, the author of the short story collections And I Do Not Forgive You and The Unfinished World. Her writing has appeared in The Paris Review, Granta, Slate, and elsewhere. Her book Happy People Don't Live Here was published in October 2025.    The episode drops on November 18.    Please go to ceasefiretoday.org, and/or https://act.uscpr.org/a/letaidin to call your congresspeople and demand an end to the forced famine and destruction of Gaza and the Gazan people.

"(Climate modelling)…it's being used in things like insurance companies. It's being used by companies for their ESG assessments. So, when you get your insurance premium at the end of the year, there is some kind of climate model that has said something about the risk of your house to flood. It has said something about your risk to fire. And so that might be driving up your insurance premium…And so it's being involved in your lives in many different ways. The food you consume, those grocery bills, there's prices behind it that are being driven by people using climate models saying something about the supply chain." Maria Caffrey on Electric Ladies Podcast Climate modelling is the foundation of a lot of planning and equations that so much of our economy and policy is based on. So, how does it work and how reliable is it? How can they tell? Listen to Maria Caffrey, Principal Scientist at the UK's National Physical Laboratory in this fascinating conversation with Electric Ladies Podcast host Joan Michelson. You'll hear about: ●        How climate modelling actually works, and who uses it and why. ●        How climate modelling measures risk and how reliable it really is – especially at a time of geological and weather patterns never seen before. ●        What the economic and social impact is of how climate modelling is used today. ●        Plus, career advice, such as:   Read Joan's Forbes articles here. You'll also like: ·       Predicting Climate Impacts In Neighborhoods – with Jessica Filante Farrington, AT&T's Director of Global Sustainability ·       The Politics of Climate & Energy – with Congresswoman Chrissy Houlahan, Co-Chair, Bipartisan Climate Solutions Caucus ·       AI and Climate Solutions – with Stephanie Hare, Ph.D., Researcher, Author of "Technology Is Not Neutral" and BBC Broadcaster ·       Climate Policy & the Economy – with Gina McCarthy, White House National Climate Advisor, Biden Administration, and former EPA Administrator under President Obama   Subscribe to our newsletter to receive our podcasts, blog, events and special coaching offers.   Thanks for subscribing on Apple Podcasts or iHeartRadio and leaving us a review! Follow us on Twitter @joanmichelson

Overview This special episode of the Tick Boot Camp Podcast was recorded live at the 2nd Annual Alzheimer's Pathobiome Initiative (AlzPI) and PCOM Symposium in collaboration with Pathobiome Perspectives. Hosted by Ali Moresco in partnership with Nikki Schultek, Executive Director of AlzPI, the conversation brings the Tick Boot Camp mission of exploring infection-associated chronic illness (IACI)—like Lyme disease and other tick-borne infections—to the global Alzheimer's and neuroimmunology research community. Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen partnered with Ali and Nikki to highlight scientists whose work connects tick-borne illness, microbes, and cognitive decline. This episode features Yuri Kim, RN, Lead Clinical Research Nurse for the MAESTRO Study at the Massachusetts Institute of Technology (MIT), who is leading pioneering work to measure and understand “brain fog” in infection-associated chronic illness. Guest Yuri Kim, RN Lead Clinical Research Nurse, MAESTRO Study Massachusetts Institute of Technology (MIT) Yuri Kim is the Lead Clinical Research Nurse for the MAESTRO Study, the largest clinical study ever conducted at MIT, led by Dr. Michal “Mikki” Caspi Tal, immunologist and immunoengineer at the Massachusetts Institute of Technology. The MAESTRO Study investigates infection-associated chronic illnesses (IACI) such as chronic Lyme disease and aims to objectively measure and understand one of the most debilitating and misunderstood symptoms—brain fog. Yuri has conducted more than 170 participant study visits and integrates patient narratives with advanced neurocognitive, immune, and molecular profiling. Her background includes experience as a trauma ER nurse and clinical research manager on neurodegenerative and rare diseases such as Alzheimer's disease, chronic traumatic encephalopathy (CTE), and amyloidosis. Key Discussion Points How the MAESTRO Study combines subjective patient narratives with objective neurocognitive and biomarker data to better define and measure brain fog. Use of innovative diagnostic tools including EEG (WAVi), RightEye eye-tracking, BrainCheck cognitive testing, and NASA Lean autonomic assessments. Early findings showing slower reaction times and potential correlations between GFAP, NfL, and sCD14 with cognitive symptoms in chronic Lyme and other IACI patients. The role of immune dysregulation, gut permeability, and neuroinflammation in contributing to cognitive impairment. The need for brain fog-specific assessment tools and more research into sex and hormonal differences that may affect neurocognitive outcomes. Why validating and quantifying “invisible symptoms” is vital to patient care and the future of infection-associated chronic illness research. “Brain fog isn't just a symptom—it's a phenomenon interconnected with multiple systems. We're trying to narrow the gap between what patients report and what we can measure.” — Yuri Kim Why It Matters Yuri Kim's work at MIT bridges patient experience and advanced science to address one of the most misunderstood symptoms in infection-associated chronic illness: brain fog. Her research within the MAESTRO Study, under the leadership of Dr. Michal “Mikki” Caspi Tal, is generating objective evidence that validates patient experiences and reveals how chronic infection and immune dysregulation can cause measurable cognitive and physiological changes. By studying infection-associated brain fog in Lyme disease and other chronic conditions, Yuri and the MAESTRO team are helping to shape a new era of diagnostics and care for people living with long-term, infection-driven illness. About the Event The interview took place at the 2nd Annual Alzheimer's Pathobiome Initiative (AlzPI) and Philadelphia College of Osteopathic Medicine (PCOM) Symposium, held on October 3, 2025, at Ohio University in Dublin, Ohio. The Symposium brought together more than 20 international experts investigating how microbes, the microbiome, and the host immune response contribute to neurological and psychiatric conditions such as Alzheimer's, dementia, and PANS/PANDAS. Tick Boot Camp partnered with Ali Moresco and Nikki Schultek to capture and share the voices of scientists advancing research on infection-associated chronic illness (IACI). This episode is part of a special Tick Boot Camp series spotlighting how pathobiome and microbiome science are transforming the understanding of chronic Lyme, cognitive dysfunction, and neurodegeneration. Learn More Learn more about the Alzheimer's Pathobiome Initiative (AlzPI) View Yuri Kim's bio on the MIT website Discover more about Dr. Michal “Mikki” Caspi Tal on Tick Boot Camp Listen to Tick Boot Camp Podcast episodes, including Episode 406: Pathobiome – An Interview with Nikki Schultek and Episode 101: The Young Gun – An Interview with Alex (Ali) Moresco discussed in this interview.

Ending the government shutdown revives an expired cybersecurity law. The DoD finalizes a new model for building U.S. military cyber forces. A North Korean APT exploits Google accounts for full device control. The EU dials back AI protections in response to pressure from Big Tech companies and the U.S. government. Researchers discover a critical vulnerability in the Monsta FTP web-based file management tool. The Landfall espionage campaign targets Samsung Galaxy devices in the Middle East. Five Eyes partners fret eroding cooperation on counterintelligence and counterterrorism. Israeli spyware maker NSO Group names the former U.S. ambassador to Israel as its new executive chairman. Monday Biz Roundup. Tim Starks from CyberScoop discusses uncertainty in the federal Cyber Corp program, The friendly face of digital villainy. Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest Today we are joined by Tim Starks from CyberScoop discussing uncertainty in the federal Cyber Corp program. Selected Reading Cyber information sharing law would get extension under shutdown deal bill (CyberScoop) Don't call it Cyber Command 2.0: Master plan for digital forces will take years to implement (The Record) North Korean hackers hijack Google, KakaoTalk accounts to control South Korean phones: Report (The Straits Times) EU set to water down landmark AI act after Big Tech pressure (The Financial Times) Monsta FTP Vulnerability Exposed Thousands of Servers to Full Takeover (Hackread) Newly identified Android spyware appears to be from a commercial vendor (The Record) F.B.I. Director Is Said to Have Made a Pledge to Head of MI5, Then Broken It (The New York Times) Seeking to get off US blacklist, spyware firm NSO taps ex-envoy Friedman as chairman (The Times of Israel) Google's Wiz acquisition clears DOJ's antitrust review. (The Cyberwire) Tank interview: A hacking kingpin reveals all to the BBC (BBC News) Share your feedback. What do you think about CyberWire Daily? Please take a few minutes to share your thoughts with us by completing our brief listener survey. Thank you for helping us continue to improve our show. Want to hear your company in the show? N2K CyberWire helps you reach the industry's most influential leaders and operators, while building visibility, authority, and connectivity across the cybersecurity community. Learn more at sponsor.thecyberwire.com. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices